@FiercePharma: Is the whole morning-after contraceptive fight based on a misunderstanding about how they work?--NYT. Report | Follow @FiercePharma
> The Novartis ($NVS) drug Ilaris helped relieve symptoms in 62% of kids with severe childhood arthritis and helped one-third of them stop taking steroids, a study found. Article
> The FDA wants more data on a new, self-injecting delivery system for Amylin Pharmaceuticals' ($AMLN) diabetes drug Bydureon; the company is in the midst of bidding from potential buyers. More
> Longtime generics specialist Teva Pharmaceuticals ($TEVA) is continuing its march into the branded-drug realm. Story
> Merck ($MRK) sued to protect its nausea drug Emend from copycat versions proposed by Novartis' generics unit Sandoz and Intas Pharmaceuticals. News
> Optimer Pharmaceuticals ($OPTR) hired Stephen Webster, former CFO of Adolor, to take on the same role after its previous CFO was fired in a conflict-of-interest scandal. Report
> ISTA Pharmaceuticals ($ISTA) shareholders approved its $500 million buyout by Bausch + Lomb. Article
Biotech News
@FierceBiotech: Complete Genomics axes 55 staffers, hires financial adviser to aid in exploring "strategic alternatives." Story | Follow @FierceBiotech
@JohnCFierce: Merck may be better dumping sarcomas and focusing on other tumor types in the clinic. | Follow @JohnCFierce
@RyanMFierce: With the FDA shunning Merck's ridaforolimus bid, Ariad looks pretty smart for front-ending its licensing terms with Merck on the cancer drug. | Follow @RyanMFierce
> ASCO Highlights: Top stories from this year's meeting. Report
> Chinese scientist convicted of stealing Merck's experimental drugs. News
> Merck KGaA and Dr. Reddy's partner on a slate of antibody biosims. Story
> FDA hits trap door button on Merck's weak ridaforolimus bid. Article
Medical Devices News
@FierceMedDev: Only a few weeks left to submit your nominations for the 15 fiercest private device developers. Survey | Follow @FierceMedDev
> GE Healthcare buys Brazilian X-ray equipment company. News
> J&J/Ethicon to stop selling four vaginal mesh implants. Story
> Stryker offers $33M to settle DOJ knee implant inquiry. Article
Drug Delivery News
@DamianFierce: Zogenix is moving forward with its DosePro drug delivery platform, filing an IND for a new anti-psychotic. More | Follow @DamianFierce
> FDA wants more info on pen delivery for Amylin's Bydureon. Story
> At ASCO, unique delivery makes TDM-1 a standout. Item
> Aptar buys injectable delivery company for $207M. News
> MIT: DNA origami could safely deliver RNAi treatment. Article
Biomarkers News
> DNA tracking responses to cancer treatment. More
> A blood test for schizophrenia? Item
> Parkinson's disease gene cluster marks early diagnosis. Story
> Teens' low-fiber diets expand bellies, disease risks. Article
And Finally... The fiery debate over morning-after contraceptive may be based on incorrect, outdated ideas about how the pills work. Report